Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's arm recalls over 48,000 cartons of drug used to treat sneezing, runny or stuffy nose

Date: 05-12-2022

Dr Reddy's Laboratories’ US-based arm-- Dr Reddy's Laboratories, Inc is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets. According to USFDA, the company is recalling the affected lot due to ‘failed stability specifications’.

The New Jersey-based firm initiated the Class III recall on November 21, 2022. As per USFDA, a Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.